Rosen Law Firm is investigating a class action lawsuit against Disc Medicine after the FDA rejected its drug application, causing the stock to drop 22%. The FDA's Complete Response Letter cited uncertainties in the drug application, leading to allegations that Disc Medicine misled investors. Shareholders who bought Disc Medicine securities may seek compensation through this lawsuit without upfront fees. The law firm encourages affected investors to join the class action to recover losses.
Metaplanet has updated its capital allocation policy to hold 85% to 90% of its assets in Bitcoin, with 10% to 15% allocated to acquisitions and investments that generate recurring income. The company aims to fund most Bitcoin purchases with permanent...
AtlasClear Holdings announced stock option awards for its executive leaders and board members to support long-term retention and align interests with shareholders. The options, granted on October 1, 2026, allow purchase of shares at $0.2010 each and ...
Valor Gold Corp. announced the sudden illness and passing of its CEO, Mark Ashley, a respected leader and mentor. Alan Edwards, the Chairman, will serve as interim CEO, ensuring leadership continuity as the company advances its gold exploration proje...
PEPE meme coin surged to around $0.00000453 on October 5, surpassing the $0.00000445 resistance level after recovering from a recent selloff. Technical analysis suggests a bullish Wolfe Wave pattern that could push PEPE's price to approximately $0.00...
David Borde has been appointed president and CEO of Entergy Texas, effective October 5, 2026, succeeding Eliecer Viamontes who left for other opportunities. Borde has extensive experience in utility strategy, regulatory affairs, and finance, having s...
